An interventional study of Ginkgo biloba extract + standard treatment( paracetamol+Diclofenac100mg SR) and placebo in addition to the standard treatment in Knee Osteoarthritis, sponsored by Kufa University. Completed at 1 site in Iraq. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-09-02.
Sponsored by Kufa University · Not applicable, Interventional, and Treatment
To assess the efficacy and safety of the Ginkgo biloba extract in patients with Knee OA.
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's enrollment of 60 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →Kufa University is the lead sponsor of 14 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
the patients received Ginkgo biloba extract in addition to standard treatment
Combination Product: Ginkgo biloba extract + standard treatment( paracetamol+Diclofenac100mg SR)
the patients received a placebo in addition to the standard treatment
Combination Product: placebo in addition to the standard treatment
120 mg leaf extract , twice daily in addition to Diclofenac 100 mg Once daily + paracetamol 1g Twice daily
Also known as: Ginko Natrol company + Dolipran+Olfen 100 SR
placebo in addition to the standard treatment
KOOS score
42 item questionnaire to assess pain, other symptoms, activities of daily living (ADL), sport and recreation function (Sport/Rec) and knee-related quality of life (QOL).
Time frame: Changes occured : baseline , 2 weeks , 4 weeks ,and 8 weeks
IL-6
Serum level of interleukin 6
Time frame: Changes occured: baseline , 4 weeks,and 8 weeks
TNF-alpha
Serum level of tumour necrosis factor - alpha
Time frame: Changes occured: baseline , 4 weeks,and 8 weeks
urinary CTX-II
C-terminal telopeptide of type II collagen from urine samples
Time frame: Changes occured :baseline , 4 weeks,and 8 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kufa University